نتایج جستجو برای: ecstasy mdma

تعداد نتایج: 2964  

Journal: :Neuroscience 2008
A R Alvaro J Martins A C Costa E Fernandes F Carvalho A F Ambrósio C Cavadas

Ecstasy (3,4-methylenedioxymethamphetamine; MDMA) has potent CNS stimulant effects. Besides the acute effects of MDMA, such as psychomotor activation, euphoria, decreased appetite, and hyperthermia, long-term damage of dopaminergic and serotonergic nerve terminals in multiple brain areas have also been reported. Although some studies have demonstrated that considerable amounts of MDMA reach the...

2000
Brendon P Boot Iain S McGregor Wayne Hall

amphetamine analogue that produces euphoric and stimulant effects and a feeling of closeness towards others. For more than a decade, MDMA (colloquially known as “Ecstasy” or “E”) has been widely used by young adults as a dance-party drug. The usual recreational oral dose is 1–2 tablets (each containing about 60–120 mg of MDMA) a standard oral dose of 0·75–4·00 mg per kg in 60–80 kg people. MDMA...

Journal: :The Journal of pharmacology and experimental therapeutics 1999
M Mas M Farré R de la Torre P N Roset J Ortuño J Segura J Camí

The cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") were assessed in a double-blind, randomized, crossover, and controlled (placebo and amphetamine) clinical trial. Eight men with experience in the recreational use of MDMA participated in four 10-h experimental sessions with a 1-week washout period. Single oral doses of 125 m...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2003
Mahmoud M Iravani Michael J Jackson Mikko Kuoppamäki Lance A Smith Peter Jenner

Ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] was shown to prolong the action of L-3,4-dihydroxyphenylalanine (L-DOPA) while suppressing dyskinesia in a single patient with Parkinson's disease (PD). The clinical basis of this effect of MDMA is unknown but may relate to its actions on either dopaminergic or serotoninergic systems in brain. In normal, drug-naive common marmosets, MDMA admini...

Journal: :Brain research. Molecular brain research 2002
Weiping Peng Arumugam Premkumar Rainald Mossner Mitsunori Fukuda K Peter Lesch Rabi Simantov

3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) is a widely abused drug. In brains of mice exposed to MDMA, we recently detected altered expression of several cDNAs and genes by using the differential display polymerase chain reaction (PCR) method. Expression of one such cDNA, which exhibited 98% sequence homology with the synaptic vesicle protein synaptotagmin IV, decreased 2 h after MDMA ...

Journal: :Human brain mapping 2001
E Frei A Gamma R Pascual-Marqui D Lehmann D Hell F X Vollenweider

3,4-Methylenedioxymethamphetamine (MDMA; 'Ecstasy') is a psychostimulant drug producing heightened mood and facilitated social communication. In animal studies, MDMA effects are primarily mediated by serotonin (5-HT), but also by dopamine (DA) and possibly noradrenaline (NA). In humans, however, the neurochemical and neurophysiological basis of acute MDMA effects remains unknown. The distributi...

Journal: :The Journal of pharmacology and experimental therapeutics 2006
João Paulo Capela Andreas Meisel Artur Reis Abreu Paula Sério Branco Luísa Maria Ferreira Ana Maria Lobo Fernando Remião Maria Lurdes Bastos Félix Carvalho

3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") is a widely abused, psychoactive recreational drug. There is growing evidence that the MDMA neurotoxic profile may be highly dependent on both its hepatic metabolism and body temperature. Metabolism of MDMA involves N-demethylation to 3,4-methylenedioxyamphetamine (MDA), which is also a drug of abuse. MDMA and MDA are O-demethylenated to N-m...

Journal: :British journal of anaesthesia 2006
A P Hall J A Henry

Since the late 1980s 'Ecstasy' (3,4-methylenedioxymethamphetamine, MDMA) has become established as a popular recreational drug in western Europe. The UK National Criminal Intelligence Service estimates that 0.5-2 million tablets are consumed weekly in Britain. It has been reported that 4.5% of young adults (15-34 yr) in the UK have used MDMA in the previous 12 months. Clinically important toxic...

Journal: :Bulletin on narcotics 2005
H A A H Visser M Visser-van Leeuwen H Huizer

Various solvents can be used in the synthesis of the illicit synthetic drug methylenedioxymethamphetamine (MDMA, commonly known as Ecstasy). In the crystallization process, traces of those solvents can be trapped inside crystals; during the following tabletting process, the solvent traces remain present in the tablets. The forensic investigation of tablets for solvents may increase knowledge of...

Journal: :Synapse 2000
B Horan E L Gardner C R Ashby

In this study, we measured conditioned place preference (CPP) responses to cocaine following subchronic administration of the recreationally abused drug (+/-)-3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in male Sprague-Dawley rats. Animals were given either vehicle (1 ml/kg of distilled water, s.c.) or MDMA (20 mg/kg, s.c.) twice a day for 4 consecutive days. Two weeks later, CPP respon...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید